Cochrane Abstracts
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Insulin Secretagogues for Prevention or Delay of Type 2 Diabetes Mellitus and Its Associated Complications in Persons at Increased Risk for the Development of Type 2 Diabetes Mellitus." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435919/all/Insulin_secretagogues_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_persons_at_increased_risk_for_the_development_of_type_2_diabetes_mellitus.
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435919/all/Insulin_secretagogues_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_persons_at_increased_risk_for_the_development_of_type_2_diabetes_mellitus. Accessed December 9, 2024.
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435919/all/Insulin_secretagogues_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_persons_at_increased_risk_for_the_development_of_type_2_diabetes_mellitus
Insulin Secretagogues for Prevention or Delay of Type 2 Diabetes Mellitus and Its Associated Complications in Persons at Increased Risk for the Development of Type 2 Diabetes Mellitus [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435919/all/Insulin_secretagogues_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_persons_at_increased_risk_for_the_development_of_type_2_diabetes_mellitus.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus
ID - 435919
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435919/all/Insulin_secretagogues_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_persons_at_increased_risk_for_the_development_of_type_2_diabetes_mellitus
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
